CanAssist Breast
Early‑stage ER‑positive, HER2‑negative breast cancer
CommercialActive
Key Facts
Indication
Early‑stage ER‑positive, HER2‑negative breast cancer
Phase
Commercial
Status
Active
Company
About OncoStem Diagnostics
Cost‑effective AI‑driven breast cancer prognostic test for personalized therapy.
View full company profile